An Act specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law

S1106 · Bill · docket SD881

8 actions

In the order the legislature recorded them.

Date	Branch	Action
2023-02-16	Senate	Referred to the committee on The Judiciary
2023-02-16	House	House concurred
2023-04-27	Senate	Discharged to the committee on Health Care Financing
2023-05-01	House	House concurred
2023-05-23	Joint	Hearing scheduled for 06/06/2023 from 10:00 AM-01:00 PM in A-1
2023-06-02	Joint	Location Changed - Hearing scheduled for 06/06/2023 from 10:00 AM-04:00 PM in A-2
2023-06-05	Joint	Hearing rescheduled to 06/06/2023 from 10:00 AM-04:00 PM in A-2
2024-05-09	House	Accompanied a study order, see H4634

2 of these were struck from the record by the clerk and shown ruled through, because a struck line is part of what the record says happened.

House Rule 27 counts its reporting deadline from the day a bill is heard.

Date	Committee	Where	Status
2023-06-06	Health Care Financing (J)	A-2, 24 Beacon Street, Boston	Completed

Action	Committee
Discharge to Another Committee	Judiciary (J)
Accompanied	Health Care Financing (J)

Every action here is as the legislature published it. A bill that drew no recorded vote is the ordinary case: the House records roughly 150 a year.